Article info
PDFReview
Epstein-Barr virus (EBV) reactivation and therapeutic inhibitors
- Correspondence to Dr Jonathan R Kerr, Department of Microbiology, West Suffolk Hospitals NHS Trust, Bury Saint Edmunds, Suffolk IP33 2QZ, UK; jonathan{at}ssl-mail.com
Citation
Epstein-Barr virus (EBV) reactivation and therapeutic inhibitors
Publication history
- Received March 3, 2019
- Revised May 19, 2019
- Accepted June 10, 2019
- First published July 17, 2019.
Online issue publication
September 19, 2019
Article Versions
- Previous version (17 July 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.